Terms: = Lung cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Treatment
8 results:
1. Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease.
Noh M; Sim JY; Kim J; Ahn JH; Min HY; Lee JU; Park JS; Jeong JY; Lee JY; Lee SY; Lee HJ; Park CS; Lee HY
J Hazard Mater; 2024 Feb; 464():132932. PubMed ID: 37988864
[TBL] [Abstract] [Full Text] [Related]
2. Novel NCOA2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases.
Bakhshwin A; Armstrong SM; Duckworth LA; Stoehr R; Konishi E; Rubin BP; Fritchie KJ; Dickson BC; Agaimy A; Dermawan JK
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23203. PubMed ID: 37724942
[TBL] [Abstract] [Full Text] [Related]
3. Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor.
Tang J; Shu D; Fang Z; Yang G
Radiol Oncol; 2023 Sep; 57(3):325-336. PubMed ID: 37665741
[TBL] [Abstract] [Full Text] [Related]
4. Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3).
Shi Y; Wu L; Yu X; Xing P; Wang Y; Zhou J; Wang A; Shi J; Hu Y; Wang Z; An G; Fang Y; Sun S; Zhou C; Wang C; Ye F; Li X; Wang J; Wang M; Liu Y; Zhao Y; Yuan Y; Feng J; Chen Z; Shi J; Sun T; Wu G; Shu Y; Guo Q; Zhang Y; Song Y; Zhang S; Chen Y; Li W; Niu H; Hu W; Wang L; Huang J; Zhang Y; Cheng Y; Wu Z; Peng B; Sun J; Mancao C; Wang Y; Sun L
Cancer Commun (Lond); 2022 Dec; 42(12):1314-1330. PubMed ID: 36336841
[TBL] [Abstract] [Full Text] [Related]
5. ctcf-mediated genome organization and leukemogenesis.
Qiu Y; Huang S
Leukemia; 2020 Sep; 34(9):2295-2304. PubMed ID: 32518417
[TBL] [Abstract] [Full Text] [Related]
6. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
[TBL] [Abstract] [Full Text] [Related]
7. ctcf and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
[TBL] [Abstract] [Full Text] [Related]
8. Dynamic transcriptional regulatory complexes including BORIS, ctcf and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
[TBL] [Abstract] [Full Text] [Related]
